PURPOSE: The aim of this study was to assess the stability of the glycosaminoglycan (GAG) content in the long term after matrix-associated autologous chondrocyte transplantation (MACT) with Hyalograft C in the knee over a follow-up period of one year. METHODS: In this cross-sectional evaluation, 11 patients after MACT of the knee consented to delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) measurements. The mean post-operative interval before the first MR examination was 40.6 ± 22.0 months, and the second MR examination was carried out after another 12 months. The Lysholm score was assessed for clinical evaluation. Quantitative T1 measurements after intravenous negatively charged MR contrast agent administration were performed. Global post-contrast T1 of the reference cartilage and the repair tissue and a relative post-contrast T1 value were calculated. RESULTS: The Lysholm score improved significantly from 59.8 ± 12.9 at baseline to 86.1 ± 15.7 at the second visit (p < 0.01). The mean global T1 of the repair tissue (1st visit 581.3 ± 126.4 ms; 2nd visit 684.1 ± 169.9 ms; p = 0.104) and the mean relative T1 value showed stable results over one year (1st visit 0.81 ± 0.28; 2nd visit 0.76 ± 0.32; p = 0.4). CONCLUSIONS: The study demonstrated stable glycosaminoglycan content of the repair tissue after MACT at midterm.
PURPOSE: The aim of this study was to assess the stability of the glycosaminoglycan (GAG) content in the long term after matrix-associated autologous chondrocyte transplantation (MACT) with Hyalograft C in the knee over a follow-up period of one year. METHODS: In this cross-sectional evaluation, 11 patients after MACT of the knee consented to delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) measurements. The mean post-operative interval before the first MR examination was 40.6 ± 22.0 months, and the second MR examination was carried out after another 12 months. The Lysholm score was assessed for clinical evaluation. Quantitative T1 measurements after intravenous negatively charged MR contrast agent administration were performed. Global post-contrast T1 of the reference cartilage and the repair tissue and a relative post-contrast T1 value were calculated. RESULTS: The Lysholm score improved significantly from 59.8 ± 12.9 at baseline to 86.1 ± 15.7 at the second visit (p < 0.01). The mean global T1 of the repair tissue (1st visit 581.3 ± 126.4 ms; 2nd visit 684.1 ± 169.9 ms; p = 0.104) and the mean relative T1 value showed stable results over one year (1st visit 0.81 ± 0.28; 2nd visit 0.76 ± 0.32; p = 0.4). CONCLUSIONS: The study demonstrated stable glycosaminoglycan content of the repair tissue after MACT at midterm.
Authors: Giuseppe Filardo; Elizaveta Kon; Alessandro Di Martino; Francesco Iacono; Maurilio Marcacci Journal: Am J Sports Med Date: 2011-07-29 Impact factor: 6.202
Authors: Daniel B F Saris; Johan Vanlauwe; Jan Victor; Karl Fredrik Almqvist; Rene Verdonk; Johan Bellemans; Frank P Luyten Journal: Am J Sports Med Date: 2009-10-21 Impact factor: 6.202
Authors: Thomas R Niethammer; Kerstin Limbrunner; Oliver B Betz; Mehmet F Gülecyüz; Matthias F Pietschmann; Markus Feist; Peter E Müller Journal: Int Orthop Date: 2015-06-25 Impact factor: 3.075
Authors: Thomas R Niethammer; Thomas Niethammer; Siegfried Valentin; Andreas Ficklscherer; Mehmet F Gülecyüz; Mehmet Gülecyüz; Matthias F Pietschmann; Matthias Pietschmann; Peter E Müller; Peter Müller Journal: Int Orthop Date: 2015-05-07 Impact factor: 3.075
Authors: Christian Albrecht; Brigitte Tichy; Sylvia Nürnberger; Lukas Zak; Markus Johannes Handl; Stefan Marlovits; Silke Aldrian Journal: Int Orthop Date: 2013-07-17 Impact factor: 3.075
Authors: Pia M Jungmann; Thomas Baum; Jan S Bauer; Dimitrios C Karampinos; Benjamin Erdle; Thomas M Link; Xiaojuan Li; Siegfried Trattnig; Ernst J Rummeny; Klaus Woertler; Goetz H Welsch Journal: Biomed Res Int Date: 2014-05-04 Impact factor: 3.411